These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 34630377)

  • 1. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses.
    Labarrere CA; Kassab GS
    Front Immunol; 2021; 12():652252. PubMed ID: 34630377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
    O'Connell P; Aldhamen YA
    Hum Vaccin Immunother; 2020 Dec; 16(12):2980-2991. PubMed ID: 32878546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity: the first line of defense against SARS-CoV-2.
    Diamond MS; Kanneganti TD
    Nat Immunol; 2022 Feb; 23(2):165-176. PubMed ID: 35105981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
    Schijns V; Lavelle EC
    Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System.
    Anaeigoudari A; Mollaei HR; Arababadi MK; Nosratabadi R
    Inflammation; 2021 Dec; 44(6):2151-2169. PubMed ID: 34524614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development.
    Ansariniya H; Seifati SM; Zaker E; Zare F
    Biomed Res Int; 2021; 2021():8870425. PubMed ID: 33564683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
    Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
    Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
    Kouwaki T; Nishimura T; Wang G; Oshiumi H
    Front Immunol; 2021; 12():700926. PubMed ID: 34249006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.
    De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC
    Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immune Responses against Coronavirus Infections: Friend or Foe?
    Vafaeinezhad A; Atashzar MR; Baharlou R
    Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
    Malireddi RKS; Sharma BR; Kanneganti TD
    Annu Rev Immunol; 2024 Jun; 42(1):615-645. PubMed ID: 38941608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus infections and immune responses.
    Li G; Fan Y; Lai Y; Han T; Li Z; Zhou P; Pan P; Wang W; Hu D; Liu X; Zhang Q; Wu J
    J Med Virol; 2020 Apr; 92(4):424-432. PubMed ID: 31981224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.
    Fung TS; Liu DX
    Annu Rev Microbiol; 2021 Oct; 75():19-47. PubMed ID: 33492978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
    Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
    Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.
    Yaqinuddin A
    Med Hypotheses; 2020 Nov; 144():110049. PubMed ID: 32758887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.